Ixabepilone Administered Weekly or Every Three Weeks in HER2-Negative Metastatic Breast Cancer Patients; A Randomized Non-Comparative Phase II Trial
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ixabepilone Administered Weekly or Every Three Weeks in HER2-Negative Metastatic Breast Cancer Patients; A Randomized Non-Comparative Phase II Trial
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 7, Pages e69256
Publisher
Public Library of Science (PLoS)
Online
2013-07-24
DOI
10.1371/journal.pone.0069256
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ixabepilone-associated peripheral neuropathy: data from across the phase II and III clinical trials
- (2012) Linda T. Vahdat et al. SUPPORTIVE CARE IN CANCER
- Ixabepilone development across the breast cancer continuum: a paradigm shift
- (2012) N K Ibrahim Cancer Management and Research
- Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) Study
- (2011) A. Psyrri et al. ANNALS OF ONCOLOGY
- Gene expression profiling of breast tumor cell lines to predict for therapeutic response to microtubule-stabilizing agents
- (2011) Gais Kadra et al. BREAST CANCER RESEARCH AND TREATMENT
- Beyond taxanes: the next generation of microtubule-targeting agents
- (2011) Javier Cortes et al. BREAST CANCER RESEARCH AND TREATMENT
- The role of Tau protein in resistance to paclitaxel
- (2011) Marta Smoter et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Retrospective study of the impact of pharmacogenetic variants on paclitaxel toxicity and survival in patients with ovarian cancer
- (2011) Troels K. Bergmann et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- II-Tubulin and III-Tubulin Mediate Sensitivity to Peloruside A and Laulimalide, but not Paclitaxel or Vinblastine, in Human Ovarian Carcinoma Cells
- (2011) A. Kanakkanthara et al. MOLECULAR CANCER THERAPEUTICS
- Ixabepilone, a New Treatment Option for Metastatic Breast Cancer
- (2010) Deborah L. Toppmeyer et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Comparison of gene expression profiling by reverse transcription quantitative PCR between fresh frozen and formalin-fixed, paraffin-embedded breast cancer tissues
- (2010) Iker Sánchez-Navarro* et al. BIOTECHNIQUES
- Efficacy of ixabepilone in ER/PR/HER2-negative (triple-negative) breast cancer
- (2010) Edith A. Perez et al. BREAST CANCER RESEARCH AND TREATMENT
- Optimizing ixabepilone treatment schedules in patients with advanced or metastatic breast cancer
- (2010) Nancy Egerton CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Automated Extraction of DNA and RNA from a Single Formalin-Fixed Paraffin-Embedded Tissue Section for Analysis of Both Single-Nucleotide Polymorphisms and mRNA Expression
- (2010) G. Hennig et al. CLINICAL CHEMISTRY
- Randomized Phase III Trial of Ixabepilone Plus Capecitabine Versus Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane
- (2010) Joseph A. Sparano et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer mortality in Europe, 2000–2004, and an overview of trends since 1975
- (2009) C. La Vecchia et al. ANNALS OF ONCOLOGY
- Evaluation of Microtubule-Associated Protein-Tau Expression As a Prognostic and Predictive Marker in the NSABP-B 28 Randomized Clinical Trial
- (2009) Lajos Pusztai et al. JOURNAL OF CLINICAL ONCOLOGY
- Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial
- (2008) George Pentheroudakis et al. BREAST CANCER RESEARCH AND TREATMENT
- A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer
- (2008) G. Fountzilas et al. BREAST CANCER RESEARCH AND TREATMENT
- Pharmacodynamics of Tubulin and Tubulin-Binding Agents: Extending Their Potential Beyond Taxanes
- (2008) Eleni Andreopoulou et al. Clinical Breast Cancer
- Phase II Genomics Study of Ixabepilone as Neoadjuvant Treatment for Breast Cancer
- (2008) José Baselga et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now